semaglutide hashimotos Compounded for Hypothyroid Is this hashimoto's related or

Such agonists are used to treat patients with type 2 diabetes, including short-acting, intermediate-acting, and long-acting therapies1

A multicenter observational study in Japan published in the Frontiers in Clinical Diabetes and Healthcare found that individuals with type 2 diabetes taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) showed reduced external eating scores after 12 months of therapy Their blood sugar levels, body weight, and body fat percentage also decreased significantly Emotional and restrained eating showed only transient changes

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

White participants comprised 43.4% of cases and 46.3% of controls, and Black participants 27.3% and 25.4%, respectively

ED isnt the same as low libido, but they can overlap

*Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial.* January 2025